Eric d'Esparbes
2022 - BIORA THERAPEUTICS
In 2022, Eric d'Esparbes earned a total compensation of $1.7M as EVP, Chief Financial Officer at BIORA THERAPEUTICS, a 5% increase compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $146,003 |
---|---|
Option Awards | $576,680 |
Salary | $486,130 |
Stock Awards | $450,998 |
Other | $19,773 |
Total | $1,679,584 |
d'Esparbes received $576.7K in option awards, accounting for 34% of the total pay in 2022.
d'Esparbes also received $146K in non-equity incentive plan, $486.1K in salary, $451K in stock awards and $19.8K in other compensation.
Rankings
In 2022, Eric d'Esparbes' compensation ranked 2,025th out of 5,753 executives tracked by ExecPay. In other words, d'Esparbes earned more than 64.8% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 2,025 | 65th |
Manufacturing | 1,086 | 65th |
Chemicals And Allied Products | 464 | 67th |
Drugs | 426 | 68th |
Pharmaceutical Preparations | 310 | 68th |
d'Esparbes' colleagues
We found two more compensation records of executives who worked with Eric d'Esparbes at BIORA THERAPEUTICS in 2022.
News
BIORA THERAPEUTICS CEO Adi Mohanty's 2023 pay slips 11% to $3.1M
April 24, 2024
BIORA THERAPEUTICS CEO Adi Mohanty's 2022 pay falls 65% to $3.5M
April 27, 2023
BIORA THERAPEUTICS CEO Adi Mohanty receives $10M in 2021
April 28, 2022
BIORA THERAPEUTICS CEO Harry Stylli's 2020 pay jumps 1,357% to $5.8M
April 15, 2021
Innoviva CEO Michael Aguiar's 2018 pay slips 11% to $3.7M
March 13, 2019